Key facts
- Sweet Chemistry’s last known valuation is $6.0M (Jun 2024).
- It has raised $3.8M across 1 recorded rounds; the latest was Seed Round ($1.6M) in Apr 2026.
- Notable investors include Imaginary Ventures, Charles Chase, Kevin Murphy, Manica Blain, Michelle Miller — 7 tracked in total.
- Sweet Chemistry has filed 1 Form D with the SEC, most recently Jun 2026 ($1.6M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Sweet Chemistry
Funding rounds
1 roundsAbout Sweet Chemistry
Manufacturer of advanced skincare products intended to address skin aging and damage. The company utilizes ECM-derived bioactive polypeptides to enhance skin barrier function, boost hydration, reduce wrinkles, and improve overall skin texture, enabling consumers to achieve healthier, firmer, and more youthful-looking skin without invasive treatments.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2023
- Website
- sweetchemistry.com/
- Ownership
- Privately Held (backing)
Sweet Chemistry doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sweet Chemistry shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sweet Chemistry in its N-PORT filings yet. We sweep new filings monthly.